The Expanding Role of Radiosurgery for Brain Metastases
AbstractStereotactic radiosurgery (SRS) has become increasingly important in the management of brain metastases due to improving systemic disease control and rising incidence. Initial trials demonstrated SRS with whole-brain radiotherapy (WBRT) improved local control rates compared with WBRT alone. Concerns with WBRT associated neurocognitive toxicity have contributed to a greater use of SRS alone, including for patients with multiple metastases and following surgical resection. Molecular information, targeted agents, and immunotherapy have also altered the landscape for the management of brain metastases. This review summarises current and emerging data on the role of SRS in the management of brain metastases. View Full-Text
Share & Cite This Article
O’Beirn, M.; Benghiat, H.; Meade, S.; Heyes, G.; Sawlani, V.; Kong, A.; Hartley, A.; Sanghera, P. The Expanding Role of Radiosurgery for Brain Metastases. Medicines 2018, 5, 90.
O’Beirn M, Benghiat H, Meade S, Heyes G, Sawlani V, Kong A, Hartley A, Sanghera P. The Expanding Role of Radiosurgery for Brain Metastases. Medicines. 2018; 5(3):90.Chicago/Turabian Style
O’Beirn, Mark; Benghiat, Helen; Meade, Sara; Heyes, Geoff; Sawlani, Vijay; Kong, Anthony; Hartley, Andrew; Sanghera, Paul. 2018. "The Expanding Role of Radiosurgery for Brain Metastases." Medicines 5, no. 3: 90.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.